The Daily cover image

Why One Drug Company Held Back a Better Drug

The Daily

Legal and Ethical Concerns in Pharmaceutical Competition

2min Snip

0
00:00
Play full episode
The strategies discussed here may not be about creating new treatments, but rather about using legal and financial power to block competition. In the case of Gilead and Tanafovir, this resulted in the delay of a potentially less harmful drug. There are both legal and ethical concerns surrounding this issue, particularly because patients' health was affected. The courts will determine whether these lawsuits can proceed based on whether Gilead knew the newer drug would be better. The key question is how much evidence was necessary for Gilead to have a responsibility to advance the drug.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode